The largest database of trusted experimental protocols

Origin software version 8

Manufactured by OriginLab
Sourced in United States

Origin is a data analysis and graphing software package developed by OriginLab. Version 8.5 includes core functionalities for data import, plotting, analysis, and report generation. The software supports a wide range of data formats and provides tools for curve fitting, statistics, and signal processing.

Automatically generated - may contain errors

29 protocols using origin software version 8

1

Triplicate Experiments with Origin Software

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments were conducted in triplicate, leading to achieve the evaluation by the mean ± standard deviation (SD). The figures were plotted by Origin Software Version 8.5 (OriginLab Corp., MA, USA).
+ Open protocol
+ Expand
2

Characterization of Nanomaterial Properties

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the data are reported as mean±standard deviation. One-way ANOVA with Tukey’s post-hoc analysis was applied to check the difference in mean values. A P-value less than 0.05 was considered as significant. The statistical analysis was performed on Origin software version 8.5 (OriginLab, Northampton, MA).
+ Open protocol
+ Expand
3

Statistical Analysis of Normalized Means

Check if the same lab product or an alternative is used in the 5 most similar protocols
Values are given as normalized means and standard deviation of the mean. Statistical comparisons intragroup and between groups were performed with t test using Origin software version 8.5 (OriginLab, Northampton, MA), after submitting data to Levenne and Shapiro-Wilk tests to confirm homogeneity and normality. Results were considered significant if p<0.05.
+ Open protocol
+ Expand
4

Comparative Analysis of Protein Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Values are provided as mean and standard deviation. Statistical comparisons within and between groups were performed with t test using Origin software version 8.5 (OriginLab, Northampton, MA, USA) after submitting data to Levenne and Shapiro-Wilk tests to confirm homogeneity and normality. Results were considered significant if P<0.05.
+ Open protocol
+ Expand
5

Plasma Fibrinolytic Potential Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma fibrinolytic potential was determined using a turbidity assay.28 (link) tPA (80 ng/mL tPA; Actilyse, Boehringer Ingelheim, Ingelheim, Germany) was added to plasma containing 17 mmol/L CaCl2, tissue factor (TF) (1,750 × diluted TF; Dade Innovin, Siemens Healthcare Diagnostics Inc., Marburg, Germany) and 10 mmol/L phospholipid vesicles (Rossix, Mölndal, Sweden). The tPA and TF concentrations were selected to obtain CLTs between 60 and 100 minutes. To determine clotting and lysis times from the resultant curves, sigmoidal curve fitting was used (Origin software version 8.5 [Origin lab, 2010]). Lag time (minutes), slope (×10−3 au/s), maximum absorbance (Δau), and CLT (minutes) were calculated as previously described.6 (link)
+ Open protocol
+ Expand
6

Fibrinolytic Potential of Plasma Clots

Check if the same lab product or an alternative is used in the 5 most similar protocols
A modified turbidity assay [35 (link)] was used to determine formation, structure, and fibrinolytic potential of plasma clots. Final concentrations were 80 ng/mL tissue plasminogen activator (tPA; Actilyse, Boehringer Ingelheim, Ingelheim, Germany), 17 mM CaCl2, 1750× diluted tissue factor (TF; Dade Innovin, Siemens Healthcare Diagnostics Inc., Marburg, Germany) and 10 mM phospholipid vesicles (Rossix, Mölndal, Sweden). The TF and tPA concentrations were selected to obtain clot lysis times (CLTs) between 60 and 100 min in control plasma. Sigmoidal curve fitting [Origin® software version 8.5 (Origin lab®, 2010)] was used to determine clot lysis time (CLT). Lag time (minutes), slope (×10−3 au/s), and maximum absorbance (Δau) were calculated as previously described [34 (link)].
+ Open protocol
+ Expand
7

Data Analysis Software Utilization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data processing and graphical representations were conducted using Origin software version 8.5 (OriginLab Corp., MA, USA). Statistical analyses were performed using SPSS 19.0 (IBM Inc., Chicago, IL, USA) with a significance level of P < 0.05.
+ Open protocol
+ Expand
8

Anlotinib's Effects on OSA Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed by Bonferroni’s correction with or without two-way ANOVA methods using SPSS (Version No. 8.0; IBM Corporation, Armonk, NY, USA). The IC50 values of anlotinib on OSA cells were calculated by Origin Software, version 8.5 (OriginLab, Northampton, MA, USA). A P-value of <0.05 was considered statistically significant between the results from two groups.
+ Open protocol
+ Expand
9

Triplicates ANOVA Analysis with Origin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise specified, all experiments in this study were performed in triplicates. An analysis of variance (ANOVA) was carried out using the SAS program version 8.1 (SAS Institute Inc., Cary, NC, USA). The least significant difference (LSD) was computed at p < 0.05. All figures were drawn using Origin software version 8.5 (Origin Lab Corp., Northampton, MA, USA). Error bars denote standard deviation of the mean.
+ Open protocol
+ Expand
10

Comparative Analysis of Protein Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Values are provided as mean and standard deviation. Statistical comparisons within and between groups were performed with t test using Origin software version 8.5 (OriginLab, Northampton, MA, USA) after submitting data to Levenne and Shapiro-Wilk tests to confirm homogeneity and normality. Results were considered significant if P<0.05.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!